324 filings
Page 7 of 17
8-K
7px4017cnz6pti
29 Nov 11
Departure of Directors or Certain Officers
12:00am
8-K/A
9gkdz hhj0o
14 Nov 11
Submission of Matters to a Vote of Security Holders
12:00am
8-K
8dn236o2kvncz9
14 Nov 11
Regulation FD Disclosure
12:00am
8-K
9mpb0guzbvueb68kxp
3 Nov 11
TRiUS Data Suggests That Testim® Significantly Improved Sexual Function in Hypogonadal Men
12:00am
8-K
edwsevlt
2 Nov 11
Auxilium Pharmaceuticals, Inc. Announces Publication of U.S. CPT® Codes and Related
12:00am
8-K
fy6qp7xiamt
31 Oct 11
Departure of Directors or Certain Officers
12:00am
8-K
n3qrow
31 Oct 11
Third Quarter 2011 Financial Results and Recent Operational Highlights
12:00am
8-K
sr5zq swv
13 Oct 11
Auxilium Pharmaceuticals Announces Hypogonadism Awareness Ad Campaign Wins Medical Marketing & Media Award
12:00am
8-K
34fmegzo
3 Oct 11
Auxilium Pharmaceuticals, Inc. Announces First Patient Enrolled in XIAFLEX® Phase
12:00am
8-K
tc2sqkcv44ngeli
13 Sep 11
Regulation FD Disclosure
12:00am
8-K
iayk58mcmff32x00s9u7
8 Sep 11
Auxilium Pharmaceuticals Announces Additional Data from Three-Year XIAFLEX® Recurrence Study in Dupuytren’s Contracture in E-poster at ASSH Meeting
12:00am
8-K
e7crz
7 Sep 11
Auxilium Pharmaceuticals, Inc. Announces Positive
12:00am
8-K
3u7biej
7 Sep 11
Regulation FD Disclosure
12:00am
8-K
1m17gk51 p65l5yz0136
6 Sep 11
Regulation FD Disclosure
12:00am
8-K
zw2ttiy0roae
6 Sep 11
Regulation FD Disclosure
12:00am
8-K
avtf wzj3zhp6z1
1 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
uqerzmp r2
8 Aug 11
Auxilium Pharmaceuticals, Inc. Announces Promotion of Dr. James P. Tursi to
12:00am
8-K
k54d7c59282lq e220dq
1 Aug 11
Second Quarter 2011 Financial Results and Recent Operational Highlights
12:00am
8-K
4q705na a1o
30 Jun 11
Auxilium Pharmaceuticals Announces Results from Three Year
12:00am
8-K
n5x8355gq
20 Jun 11
Submission of Matters to a Vote of Security Holders
12:00am